Topics

[Comment] Carbapenem-resistant Enterobacteriaceae: global action required

21:37 EDT 29 Apr 2019 | The Lancet

Enterobacteriaceae are common pathogens in hospitals and in the community. When resistant to powerful and versatile antibiotics such as carbapenems, they can have devastating consequences, particularly in the most vulnerable individuals.1 Much information about the clinical impact of carbapenem-resistant Enterobacteriaceae (CRE) comes from high-income countries.2,3 Yet, the brunt of the CRE epidemic is borne by low-income and middle-income countries (LMICs), which must also cope with fragile health-care systems that are often overburdened.

Original Article: [Comment] Carbapenem-resistant Enterobacteriaceae: global action required

NEXT ARTICLE

More From BioPortfolio on "[Comment] Carbapenem-resistant Enterobacteriaceae: global action required"

Quick Search